Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide for High Risk Acute Pediatric Leukemia. Promising Results Using a Protocol with Peripheral Blood and a Medium Intensity ConditioningAmado Karduss, Giovanni Ruiz, Luis Rodolfo Manosalvas Gómez et al.|Blood|2015Cited by 1
Long Term Follow up of Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide in Children and Teenagers < 18 Years Old with High-Risk Acute Leukemia. Very Good Results in CR1 and CR2 Patients but Unexpected High Incidence of Severe Acute Graft Versus Host Disease in Children < 10 YearsÁngela Maria Trujillo, Luis Rodolfo Manosalvas Gómez, Amado Karduss et al.|Blood|2017Cited by 1
Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide Using As Conditioning Fludarabine Melphalan Plus 200-400cGy of Total Body Irradiation. Very Good Balance Between Tolerance and Anti Leukemic ActivityAmado Karduss, Angélica Cardona, Luis Rodolfo Manosalvas Gómez et al.|Blood|2016Cited by 0